Why Invest in BioPhenolics?
A Breakthrough in Phenolic Bioproduction
Our proprietary microbial metabolic engineering platform enables high‑efficiency production of phenolic compounds — a category traditionally dependent on petroleum.
Positioned for Deeptech & Sustainability Investors
Ideal for:
-
Seed–Series A deeptech VCs
-
Sustainability‑focused funds
-
Family offices
-
Strategic investors in chemical and cosmetics industries
Market Opportunity
A $15B+ Global Market Ready for Disruption
Phenolic compounds are essential to modern manufacturing. As industries seek safer, greener alternatives, BioPhenolics is positioned to lead the transition from petrochemical to bio‑based production.
Our Roadmap
Short-Term (6-12 months)
-
Pilot‑scale bioproduction of phenolic compounds
-
Development of next‑generation fermenter system
Long-Term (5+ years)
-
Commercial biofactories in Southeast Asia
-
Multi‑industry integration of bio‑based phenolics
Leadership Team
BioPhenolics Inc. was founded by experts in microbial metabolic engineering and bioprocess development to revolutionize sustainable chemical production.
President and CEO
NUKUI Noriyuki, Ph.D.
Industry expert in bioprocess development and scale‑up.
Chief Technology Officer
Prof. TAKAYA Naoki, Ph.D.
Professor of Life & Environmental Sciences at the University of Tsukuba. Expert in microbial metabolism and biomass utilization.
Chief Operations Officer
Mr. INABA Kazuki
Mr. Inaba leads strategy, business development, and commercialization at BioPhenolics, drawing on 15 years of global engineering and consulting experience to accelerate the shift from petroleum‑based to bio‑based chemical manufacturing.
Business Development
Takuma Kanesaki
Primary contact for partnerships and investor relations. A global manager with a customer centric mindset.
Biotech enthusiast.
